SNYR:NSD-Synergy CHC Corp. Common Stock (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 3.87

Change

-0.01 (-0.13)%

Market Cap

N/A

Volume

4.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

-0.81 (-1.04%)

USD 9.93B
PDCO Patterson Companies Inc

+0.01 (+0.03%)

USD 2.73B
AHG Akso Health Group ADR

-0.03 (-2.26%)

USD 0.35B
EDAP EDAP TMS SA

-0.14 (-5.15%)

USD 0.11B
YI 111 Inc

+0.16 (+1.95%)

USD 0.05B
COSM Cosmos Health Inc.

-0.01 (-1.89%)

N/A
ZYXI Zynex Inc

-0.22 (-2.97%)

N/A

ETFs Containing SNYR

MVA:AU VanEck Vectors Australian.. 7.66 % 0.00 %

+0.19 (+0.22%)

USD 0.59B
SLF:AU SPDR S&P/ASX 200 Listed P.. 4.27 % 0.00 %

-0.08 (0.22%)

USD 0.56B
VAP:AU Vanguard Australian Prope.. 4.13 % 0.00 %

+1.89 (+0.22%)

USD 2.97B
DVDY:AU VanEck Morningstar Austra.. 4.06 % 0.00 %

-0.06 (0.22%)

USD 0.08B
SMLL:AU BetaShares Australian Sma.. 3.15 % 0.00 %

-0.01 (0.22%)

N/A
VSO:AU Vanguard MSCI Australian .. 1.64 % 0.00 %

+0.15 (+0.22%)

USD 0.95B
1555:TSE Nikko Australia REIT 0.00 % 0.00 %

+23.50 (+0.22%)

USD 15.35B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.05% 13% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.05% 13% F 25% F
Trailing 12 Months  
Capital Gain 38,600.00% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 38,600.00% 100% F 100% F
Trailing 5 Years  
Capital Gain 6,350.00% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6,350.00% 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 2,381.00% 100% F 99% N/A
Dividend Return 2,381.00% 100% F 99% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9,525.06% 13% F 2% F
Risk Adjusted Return 25.00% 75% C 57% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.